The Company of Biologists, UK, has launched a new journal - Disease Models & Mechanisms (DMM) - focusing on translational research and use of model organisms to advance human health. Vivian Siegel will serve as the Editor-in-Chief of the journal, the inaugural issue of which was launched both in print and online at http://DMM.biologists.org.
DMM focuses on human disease and the research necessary to develop treatments for illness. The field of translational medicine - where basic science research is translated' into treatments and cures for disease - has been growing exponentially, particularly given the recent advances in genomics and life sciences, and shifts in global research funding. The journal aims to fill a niche in translational research by publishing articles about human disease and the model organisms used in biomedical research.
The special inaugural issue features editorial commentary, review articles, and research highlights on topics ranging from cancer detection, to understanding human diseases using flies or worms and the future impact of mouse genetics on humankind. Future issues will include primary research articles. DMM continues to invite authors to submit articles which focus on human disease.
Disease Models & Mechanisms will publish 5 issues in 2008. Issue 1 is a special inaugural issue; issues 2/3 and 4/5 will be combined double issues. From 2009, DMM will be published every month. Authors benefit from a free trial period for access to DMM, which will be available until spring 2009.
